Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Immunochemotherapy successfully treated neutropenia in a patient with Waldenström's macroglobulinemia.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

Denosumab treatment for osteoporosis can cause hair loss.

Researchers created a rat model to study skin damage caused by radiation, which could help develop new treatments.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

The study's findings are unreliable due to retraction.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

The convention highlighted knowledge sharing, networking, and the importance of active participation in dermatology.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Notch signaling is essential for healthy skin and hair follicle maintenance.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Hedgehog signaling is essential for normal sebaceous gland development and affects keratin 6a expression.

Quercetin effectively treated and prevented hair loss in mice.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Platelet-rich plasma improves bladder function and reduces overactivity in ketamine-induced bladder issues.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

Targeting non-Smad pathways in TGF-β signaling may improve keloid treatment.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

New drug delivery systems show promise in effectively treating pathological scars.

High homocysteine levels in lupus may increase inflammation and cardiovascular risk.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.